NCT06028451

Brief Summary

To assessed the current situation and outcome of critically ill patients with invasive aspergillus infection.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
550

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 31, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 8, 2023

Completed
17 days until next milestone

Study Start

First participant enrolled

September 25, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2024

Completed
Last Updated

October 10, 2023

Status Verified

October 1, 2023

Enrollment Period

12 months

First QC Date

August 31, 2023

Last Update Submit

October 7, 2023

Conditions

Invasive Aspergillosis

Keywords

invasive aspergillus infection

Outcome Measures

Primary Outcomes (1)

  • mortality

    28 day

Study Arms (2)

Survivors

Critically ill patients with invasive aspergillus infection who survived

Other: Record the information data

Nonsurvivors

Critically ill patients with invasive aspergillus infection who not survived

Other: Record the information data

Interventions

Record the information dataOTHER

Record the information data

NonsurvivorsSurvivors

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagosed as invasive aspergillosis

You may qualify if:

  • Age\>18 year-old
  • Diagosed as invasive aspergillus infection

You may not qualify if:

  • Pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Southeast University, Zhongda hospital

Nanjing, Jiangsu, 210000, China

RECRUITING

Study Officials

  • Jingyuan Xu, M.D.

    Southeast University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jingyuan Xu, M.D.

CONTACT

861385141720913851417209@163.com

Jingyuan Xu, M.D.

CONTACT

1385141720913851417209@163.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
90 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 31, 2023

First Posted

September 8, 2023

Study Start

September 25, 2023

Primary Completion

September 15, 2024

Study Completion

December 15, 2024

Last Updated

October 10, 2023

Record last verified: 2023-10

Locations

CN(1)